275 related articles for article (PubMed ID: 29777744)
1. Omalizumab can inhibit respiratory reaction during aspirin desensitization.
Lang DM; Aronica MA; Maierson ES; Wang XF; Vasas DC; Hazen SL
Ann Allergy Asthma Immunol; 2018 Jul; 121(1):98-104. PubMed ID: 29777744
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
[No Abstract] [Full Text] [Related]
3. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.
Jean T; Eng V; Sheikh J; Kaplan MS; Goldberg B; Jau Yang S; Samant S
Allergy Asthma Proc; 2019 Sep; 40(5):316-320. PubMed ID: 31514790
[No Abstract] [Full Text] [Related]
4. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
[TBL] [Abstract][Full Text] [Related]
5. A trial of type 12 purinergic (P2Y
Laidlaw TM; Cahill KN; Cardet JC; Murphy K; Cui J; Dioneda B; Kothari P; Raby BA; Israel E; Boyce JA
J Allergy Clin Immunol; 2019 Jan; 143(1):316-324.e7. PubMed ID: 29890239
[TBL] [Abstract][Full Text] [Related]
6. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
Eastman JJ; Cavagnero KJ; Deconde AS; Kim AS; Karta MR; Broide DH; Zuraw BL; White AA; Christiansen SC; Doherty TA
J Allergy Clin Immunol; 2017 Jul; 140(1):101-108.e3. PubMed ID: 28279492
[TBL] [Abstract][Full Text] [Related]
7. Factors correlated with repeated aspirin dosing during aspirin desensitization.
Schuler CF; Baldwin JL; Baptist AP
Ann Allergy Asthma Immunol; 2018 Jul; 121(1):111-116.e1. PubMed ID: 29653235
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease.
Hayashi H; Mitsui C; Nakatani E; Fukutomi Y; Kajiwara K; Watai K; Sekiya K; Tsuburai T; Akiyama K; Hasegawa Y; Taniguchi M
J Allergy Clin Immunol; 2016 May; 137(5):1585-1587.e4. PubMed ID: 26559322
[No Abstract] [Full Text] [Related]
9. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
[TBL] [Abstract][Full Text] [Related]
10. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
[TBL] [Abstract][Full Text] [Related]
11. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
[TBL] [Abstract][Full Text] [Related]
12. Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease.
Ta V; White AA
J Allergy Clin Immunol Pract; 2015; 3(5):711-8. PubMed ID: 25858054
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.
Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Tomita Y; Kamide Y; Tsuburai T; Sekiya K; Ishii M; Hasegawa Y; Taniguchi M
J Allergy Clin Immunol; 2023 Jun; 151(6):1667-1672.e2. PubMed ID: 36967017
[TBL] [Abstract][Full Text] [Related]
14. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
DeGregorio GA; Singer J; Cahill KN; Laidlaw T
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
[TBL] [Abstract][Full Text] [Related]
15. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
[TBL] [Abstract][Full Text] [Related]
16. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241
[TBL] [Abstract][Full Text] [Related]
17. Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
Mullur J; Steger CM; Gakpo D; Bensko JC; Maurer R; Laidlaw TM; Buchheit KM
Ann Allergy Asthma Immunol; 2022 May; 128(5):575-582. PubMed ID: 35131410
[TBL] [Abstract][Full Text] [Related]
18. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
19. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
Laidlaw TM; Buchheit KM; Cahill KN; Hacker J; Cho L; Cui J; Feng C; Chen CC; Le M; Israel E; Boyce JA
J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712
[TBL] [Abstract][Full Text] [Related]
20. Aspirin-exacerbated respiratory disease: an update.
Le Pham D; Lee JH; Park HS
Curr Opin Pulm Med; 2017 Jan; 23(1):89-96. PubMed ID: 27653792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
